UnknownNot applicableNCT05562284
Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion
Studying Central retinal artery occlusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Principal Investigator
- Ping Fei, MD#PhDXinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Intervention
- intra-arterial thrombolysis(procedure)
- Enrollment
- 128 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2022 – 2024
Study locations (1)
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05562284 on ClinicalTrials.govOther trials for Central retinal artery occlusion
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07482228Long-term Clinical Outcomes After Retinal Artery OcclusionChonnam National University Hospital
- RECRUITINGNANCT07151755Microneedle Intra-Arterial Injection for Retinal Artery OcclusionSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06500728Visual Involvement in Giant Cell ArteritisASST Fatebenefratelli Sacco
- RECRUITINGPHASE3NCT04965038Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery OcclusionUniversity Hospital Tuebingen
- RECRUITINGNANCT07545473Retinal Hyperspectral Imaging in Neurodegenerative DiseasesCenter for Eye Research Australia